NCT00918333 2020-03-10Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed124 enrolled 10 charts
NCT00474929 2019-08-20Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaMayo ClinicPhase 1/2 Completed103 enrolled 12 charts
NCT02240719 2019-01-04Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic CancerUniversity of California, DavisPhase 1 Completed20 enrolled
NCT00729638 2014-08-11RAD001 and Lenalidomide in the Treatment of Subjects With Relapsed and Relapsed/Refractory Multiple MyelomaMassachusetts General HospitalPhase 1 Completed28 enrolled
NCT00962507 2013-02-15Panobinostat and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple MyelomaCity of Hope Medical CenterPhase 1 Completed11 enrolled
NCT00618345 2011-05-16Everolimus in Treating Patients With Relapsed or Refractory Multiple MyelomaMayo ClinicPhase 2 Completed35 enrolled